Prestige Consumer Healthcare Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
Business Address 660 WHITE PLAINS RD., TARRYTOWN, NY, 10591
Mailing Address 660 WHITE PLAINS RD., TARRYTOWN, NY, 10591
Phone (914) 524-6800
Fiscal Year End 0331
EIN 201297589
Financial Overview
FY2025
$214.60M
Net Income
$1.57B
Total Liabilities
$1.83B
Stockholders' Equity
$97.88M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| 8-K Current report of material events | February 5, 2026 | View on SEC |
| 10-Q Quarterly financial report | February 5, 2026 | View on SEC |
| 3 Initial insider ownership report | January 29, 2026 | View on SEC |
| 4 Insider stock transaction report | January 29, 2026 | View on SEC |
| 4 Insider stock transaction report | December 2, 2025 | View on SEC |
| 4 Insider stock transaction report | November 26, 2025 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | November 14, 2025 | View on SEC |
| 8-K Current report of material events | November 6, 2025 | View on SEC |
Insider Trading
SELL 2 insiders
4 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.